Fri-24-08-2018, 09:35 AM
I’d welcome trying that, I imagine there might be fewer side effects if you get the treatment straight to the problem area.
Nuevolution announce the identity of its “Cytokine X” program
|
« Next Oldest | Next Newest »
|
Messages In This Thread |
Nuevolution announce the identity of its “Cytokine X” program - by Fred - Wed-22-08-2018, 21:34 PM
RE: Nuevolution announce the identity of its “Cytokine X” program - by jiml - Wed-22-08-2018, 22:14 PM
RE: Nuevolution announce the identity of its “Cytokine X” program - by Caroline - Thu-23-08-2018, 09:35 AM
RE: Nuevolution announce the identity of its “Cytokine X” program - by Turnedlight - Fri-24-08-2018, 09:35 AM
|
Possibly Related Threads… | |||||
Thread | Author | Replies | Views | Last Post | |
Idera announce phase 2 trial of IMO-3100 | Fred | 3 | 5,272 |
Sat-20-03-2021, 11:29 AM Last Post: Fred |
|
Novartis will announce new evidence on Cosentyx for psoriatic arthritis | Fred | 1 | 2,803 |
Tue-07-11-2017, 14:37 PM Last Post: Fred |
|
Prothena announce disappointing results for PRX003 in Patients with Psoriasis | Fred | 0 | 2,043 |
Sat-21-10-2017, 20:42 PM Last Post: Fred |
|
Vitae announce RORyt Inhibitor VTP-43742 phase 1 results | Fred | 2 | 3,940 |
Sat-12-09-2015, 19:13 PM Last Post: Fred |
|
Akall Pharma announce positive phse 1 for AKP - 11 for psoriasis | Fred | 0 | 2,865 |
Thu-05-02-2015, 10:09 AM Last Post: Fred |